Literature DB >> 7765462

Alphavirus expression systems.

P Liljeström1.   

Abstract

Alphavirus vectors are newcomers in the field of heterologous gene expression. Nevertheless, they have rapidly become popular and are now being used in a wide range of applications. During the past year, new vectors and new methods for their use have improved levels of gene expression. As alphaviruses are capable of infecting humans, biosafety was an important issue during early work with these vectors. The construction of a conditional lethal helper system has now largely overcome this problem, and should further increase the utility of these types of vector in animal cell systems.

Entities:  

Mesh:

Year:  1994        PMID: 7765462     DOI: 10.1016/0958-1669(94)90063-9

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  16 in total

1.  Recombinant protein production using the Semliki Forest Virus expression system.

Authors:  H D Blasey; K Lundström; S Tate; A R Bernard
Journal:  Cytotechnology       Date:  1997-05       Impact factor: 2.058

2.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector.

Authors:  M J Hariharan; D A Driver; K Townsend; D Brumm; J M Polo; B A Belli; D J Catton; D Hsu; D Mittelstaedt; J E McCormack; L Karavodin; T W Dubensky; S M Chang; T A Banks
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

Authors:  X Zhou; P Berglund; H Zhao; P Liljeström; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation.

Authors:  Svetlana Atasheva; Dal Young Kim; Maryna Akhrymuk; David G Morgan; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

Review 6.  Manipulation of the Semliki Forest virus genome and its potential for vaccine construction.

Authors:  G J Atkins; B J Sheahan; P Liljeström
Journal:  Mol Biotechnol       Date:  1996-02       Impact factor: 2.695

7.  Replication and packaging of transmissible gastroenteritis coronavirus-derived synthetic minigenomes.

Authors:  A Izeta; C Smerdou; S Alonso; Z Penzes; A Mendez; J Plana-Durán; L Enjuanes
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Two-helper RNA system for production of recombinant Semliki forest virus particles.

Authors:  C Smerdou; P Liljeström
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.

Authors:  S P Mossman; F Bex; P Berglund; J Arthos; S P O'Neil; D Riley; D H Maul; C Bruck; P Momin; A Burny; P N Fultz; J I Mullins; P Liljeström; E A Hoover
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

10.  Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.

Authors:  T W Dubensky; D A Driver; J M Polo; B A Belli; E M Latham; C E Ibanez; S Chada; D Brumm; T A Banks; S J Mento; D J Jolly; S M Chang
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.